To include your compound in the COVID-19 Resource Center, submit it here.

PRN1371: Phase I data

Data from 6 evaluable patients with advanced solid tumors in the dose-escalation Part

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE